Larry Hecker and Reglagene were both honored at the Governor’s Council on Innovation hosted by AZ Tech Council.

CEO Richard Austin and Director of Operations Michael Abrahamson attended Texas Life Science Forum 2023.

Find out how we were able to enter preclinical development at 10% of the cost in the interview.

Drs. Suzuki, Patrón, and Gokhale present at the AACR Special Conference on Brain Cancer in Minneapolis, MN.

This recognition is a testament to the dedication of our incredible team at Reglagene in advancing therapies for brain diseases. Watch the video to see what drives our commitment to groundbreaking solutions and the future we're building. Thank you, Arizona BioIndustry Association (AZBio)!

Reglagene’s Richard Austin was on a panel during the AZAdvances Innovation Showcase during AZBio Week.

This award underscores the critical importance of advancing brain disease product development and the need to improve patient lives. Reglagene’s commitment to groundbreaking solutions remains steadfast, and we're excited for the future!

Richard Austin and Michael Abrahamson are joined by Board Chair Lawrence Kinet, Tripp Shannon, CFA, and Jeff Koenig at Seattle’s Keiretsu Syndication Summit & Keiretsu Family Office Forum.

Dr. Richard Austin will be presenting Reglagene at the Keiretsu Family Office Forum on August 16, 2023.